MORRIS PLAINS, N.J., May 25, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that two presentations will be given at the 2012 Annual Meeting of the American Society of Clinical Oncology scheduled for June 1 – 5, 2012, in Chicago, Illinois. The schedule and meeting places for the presentations, together with the abstract numbers are listed below:
